Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in children. Despite intensive research in recent decades the prognosis for patients with metastatic or relapsed diseases has hardly improved. New therapeutic concepts in anti-tumor therapy aim to...
The 15th biannual International Wolfsberg Meeting Series met this week, to focusing on molecular radiation biology and oncology in the historic Wolfsberg Castle in Switzerland. Along with the various attendees and sponsors, Xstrahl Medical attended to support the...
Xstrahl took part in the 23rd Annual Meeting of the German Society for Radiation Oncology (DEGRO) held on 15th – 18th June in Berlin to display its leading range of superficial radiotherapy systems. DEGRO has been the flagship event for professionals working in the...
The mission of most cancer centers, in some shape or form, is to contribute to the prevention and cure of cancer. To accomplish such a mission, a large focus must be placed on research in both the clinical and pre-clinical laboratory setting. In order to yield...
Xstrahl Medical joined the best in UK radiation oncology at the second annual UKRCO congress, focusing on new technologies and techniques to enhance patient experiences, and clinical efficiencies. “UKRCO 2017 in Manchester represented cohesion in diagnostic imaging...
PURPOSE/OBJECTIVES: Radiation-induced erectile-dysfunction (RiED) is one of the most common side effects of radiation therapy (RT) and significantly reduces the quality of life (QoL) of cancer patients. Approximately 50% of prostate cancer patients experience RiED...
Radiotherapy is under investigation for its ability to enhance responses to immunotherapy. However, the mechanisms by which radiation induces anti-tumour T cells remain unclear. We show that the DNA exonuclease Trex1 is induced by radiation doses above 12-18 Gy in...
June 7th, 2017 – Recent surveys show that over half of the British population are unaware that radiotherapy options exist for cancers, benign conditions or palliative care1. This means that thousands of patients could be missing out on the best possible treatment....
Dupuytren's contracture is incredibly common, with rates in England of 20% of the population over the age of 65 having the disease. Causing a debilitating curling of fingers and toes, the most common treatment is surgery, causing long term and painful recovery....
Contact Us